These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31377437)

  • 1. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
    Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rituximab and hypogammaglobulinemia].
    Fernández Romero DS; Torre MG; Larrauri BJ; Malbrán E; Juri MC; Malbrán A
    Medicina (B Aires); 2015; 75(5):319-23. PubMed ID: 26502469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M; Silverman ED; Levy DM
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.
    Westermann-Clark E; Meehan CA; Meyer AK; Dasso JF; Amre D; Ellison M; Patel B; Betensky M; Hauk CI; Mayer J; Metts J; Leiding JW; Sriaroon P; Kumar A; Ayala I; Walter JE
    Front Immunol; 2021; 12():649182. PubMed ID: 33968040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
    Parmentier C; Delbet JD; Decramer S; Boyer O; Hogan J; Ulinski T
    Pediatr Nephrol; 2020 Mar; 35(3):455-462. PubMed ID: 31705306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia.
    Conti F; Gottardi F; Moratti M; Belotti T; Ferrari S; Selva P; Bassi M; Zama D; Pession A
    Platelets; 2022 Jul; 33(5):801-806. PubMed ID: 35132908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenence rituximab following induction in autoimmune cytopenias.
    Rai MP; Lee EJ; Bussel JB
    Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological Involvement in Childhood Evans Syndrome.
    Pincez T; Neven B; Le Pointe HD; Varlet P; Fernandes H; Gareton A; Leverger G; Leblanc T; Chambost H; Michel G; Pasquet M; Millot F; Hermine O; Mathian A; Hully M; Zephir H; Hamidou M; Durand JM; Perel Y; Landman-Parker J; Rieux-Laucat F; Aladjidi N
    J Clin Immunol; 2019 Feb; 39(2):171-181. PubMed ID: 30671780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia.
    Matarazzo L; Di Chio T; Nastasio S; Tommasini A; Ventura A; Maggiore G
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):66-72. PubMed ID: 31076361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
    Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
    Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
    Levy R; Mahévas M; Galicier L; Boutboul D; Moroch J; Loustau V; Guillaud C; Languille L; Fain O; Bierling P; Khellaf M; Michel M; Oksenhendler E; Godeau B
    Autoimmun Rev; 2014 Oct; 13(10):1055-63. PubMed ID: 25183241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
    Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
    Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study.
    Zhang XY; Gong JY; Wang JS; Feng JY; Chen L; Xie XB; Lu Y
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102392. PubMed ID: 38897557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections.
    Taskin RB; Topyıldız E; Edeer Karaca N; Aksu G; Yılmaz Karapınar D; Kutukculer N
    Int Arch Allergy Immunol; 2024; 185(4):392-401. PubMed ID: 38154455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect.
    Ott de Bruin LM; Pico-Knijnenburg I; van Ostaijen-Ten Dam MM; Weitering TJ; Berghuis D; Bredius RGM; Lankester AC; van der Burg M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
    Labrosse R; Barmettler S; Derfalvi B; Blincoe A; Cros G; Lacombe-Barrios J; Barsalou J; Yang N; Alrumayyan N; Sinclair J; Ong MS; Camargo CA; Walter J; Haddad E
    J Allergy Clin Immunol; 2021 Aug; 148(2):523-532.e8. PubMed ID: 33862010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell hepatitis associated with autoimmune hemolytic anemia: More evidence for B-cell depletion therapy for a rare immune mediated disease of infancy.
    Maggiore G; Sciveres M
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102435. PubMed ID: 39084551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded utilization of rituximab in paediatric cardiac transplant patients.
    Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
    J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.